Marilena Flouri

1PUBLICATIONS
15CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Sep 11, 2026
Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.

Pageof 1

Frequent Collaborators

1 joint publications

Pascal Joly

1 joint publications

Dedee F Murrell

1 joint publications

Yumi Aoyama

1 joint publications

Frédéric Caux

1 joint publications

Dipankar De

1 joint publications

Matthias Goebeler

1 joint publications

Chao Ji

1 joint publications

Dimitra Kiritsi

1 joint publications

Meng Pan

1 joint publications

Aikaterini Patsatsi

Frequent Collaborators

1 joint publications

Pascal Joly

1 joint publications

Dedee F Murrell

1 joint publications

Yumi Aoyama

1 joint publications

Frédéric Caux

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

See more related videos

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

See more related videos